283 related articles for article (PubMed ID: 21245485)
1. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.
Liu Y; Johnson SM; Fedoriw Y; Rogers AB; Yuan H; Krishnamurthy J; Sharpless NE
Blood; 2011 Mar; 117(12):3257-67. PubMed ID: 21245485
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of the p16(INK4a) cyclin-dependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytes.
Lagresle C; Gardie B; Eyquem S; Fasseu M; Vieville JC; Pla M; Sigaux F; Bories JC
J Immunol; 2002 Mar; 168(5):2325-31. PubMed ID: 11859122
[TBL] [Abstract][Full Text] [Related]
3. The molecular balancing act of p16(INK4a) in cancer and aging.
LaPak KM; Burd CE
Mol Cancer Res; 2014 Feb; 12(2):167-83. PubMed ID: 24136988
[TBL] [Abstract][Full Text] [Related]
4. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.
Burd CE; Sorrentino JA; Clark KS; Darr DB; Krishnamurthy J; Deal AM; Bardeesy N; Castrillon DH; Beach DH; Sharpless NE
Cell; 2013 Jan; 152(1-2):340-51. PubMed ID: 23332765
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor Slug represses p16
Zhu P; Zhang C; Gao Y; Wu F; Zhou Y; Wu WS
Nat Commun; 2019 Jun; 10(1):2568. PubMed ID: 31189923
[TBL] [Abstract][Full Text] [Related]
6. p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.
Helman A; Klochendler A; Azazmeh N; Gabai Y; Horwitz E; Anzi S; Swisa A; Condiotti R; Granit RZ; Nevo Y; Fixler Y; Shreibman D; Zamir A; Tornovsky-Babeay S; Dai C; Glaser B; Powers AC; Shapiro AM; Magnuson MA; Dor Y; Ben-Porath I
Nat Med; 2016 Apr; 22(4):412-20. PubMed ID: 26950362
[TBL] [Abstract][Full Text] [Related]
7. Chronic expression of p16
Azazmeh N; Assouline B; Winter E; Ruppo S; Nevo Y; Maly A; Meir K; Witkiewicz AK; Cohen J; Rizou SV; Pikarsky E; Luxenburg C; Gorgoulis VG; Ben-Porath I
Nat Commun; 2020 Jun; 11(1):2711. PubMed ID: 32483135
[TBL] [Abstract][Full Text] [Related]
8. Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf.
Signer RA; Montecino-Rodriguez E; Witte ON; Dorshkind K
Genes Dev; 2008 Nov; 22(22):3115-20. PubMed ID: 19056891
[TBL] [Abstract][Full Text] [Related]
9. CREG1 enhances p16(INK4a) -induced cellular senescence.
Moolmuang B; Tainsky MA
Cell Cycle; 2011 Feb; 10(3):518-30. PubMed ID: 21263217
[TBL] [Abstract][Full Text] [Related]
10. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice.
Yousefzadeh MJ; Zhao J; Bukata C; Wade EA; McGowan SJ; Angelini LA; Bank MP; Gurkar AU; McGuckian CA; Calubag MF; Kato JI; Burd CE; Robbins PD; Niedernhofer LJ
Aging Cell; 2020 Mar; 19(3):e13094. PubMed ID: 31981461
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Randle DH; Zindy F; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of relationship between effect of ginsenoside Rg1 to delay hematopoietic stem cell senescence and expression of p16(INK4a)].
Zhou Y; Yang B; Yao X; Wang Y
Zhongguo Zhong Yao Za Zhi; 2011 Mar; 36(5):608-13. PubMed ID: 21657082
[TBL] [Abstract][Full Text] [Related]
13. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
14. p16
Novais EJ; Diekman BO; Shapiro IM; Risbud MV
Matrix Biol; 2019 Sep; 82():54-70. PubMed ID: 30811968
[TBL] [Abstract][Full Text] [Related]
15. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
Zheng Y; He L; Wan Y; Song J
Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
[TBL] [Abstract][Full Text] [Related]
16. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
17. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.
Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin II; Leonova KI; Consiglio CR; Gollnick SO; Chernova OB; Gudkov AV
Aging (Albany NY); 2017 Aug; 9(8):1867-1884. PubMed ID: 28768895
[TBL] [Abstract][Full Text] [Related]
18. Cells exhibiting strong
Liu JY; Souroullas GP; Diekman BO; Krishnamurthy J; Hall BM; Sorrentino JA; Parker JS; Sessions GA; Gudkov AV; Sharpless NE
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2603-2611. PubMed ID: 30683717
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p16
Khatiwala RV; Zhang S; Li X; Devejian N; Bennett E; Cai C
Stem Cell Rev Rep; 2018 Aug; 14(4):612-625. PubMed ID: 29675777
[TBL] [Abstract][Full Text] [Related]
20. Expression of p16
Diekman BO; Sessions GA; Collins JA; Knecht AK; Strum SL; Mitin NK; Carlson CS; Loeser RF; Sharpless NE
Aging Cell; 2018 Aug; 17(4):e12771. PubMed ID: 29744983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
